Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Drug-eluting stents (DES) reduce the rate of in-stent restenosis (ISR) compared to bare-metal stents (BMS). However, the first-generation DES had higher rates of late stent thrombosis than BMS, and this was more evident after primary percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI).

Bare-Metal or Everolimus-Eluting Stents in STEMI?